Concepedia

Publication | Closed Access

Long-Term, Open-Label Extension Study of Guanfacine Extended Release in Children and Adolescents with ADHD

DOI

270

Citations

21

References

2008

Year

J Biederman, Raun D. Melmed, Anil Patel, Keith McBurnett, Jessica Donahue, A. G. Lyne
CNS Spectrums

Abstract

Long-term treatment with GXR was generally safe for up to 24 months of treatment, and effectiveness was maintained over this treatment period.

References

YearCitations

Page 1